Jan Budczies (J Budczies)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Quality Control

Brain Metastases

Top Venues

British journal of cancer

The journal of pathology. Clinical research

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Rajiv Shah, Farastuk Bozorgmehr, Rajkumar Savai, Thorsten Stiewe, Solange Peters, Peter Schirmacher, Michael Thomas, Daniel N Kazdal, Petros Christopoulos, Albrecht Stenzinger
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma. British journal of cancer 131 (3) (2024)
Jan Budczies, Daniel N Kazdal, Michael Menzel, Susanne Beck, Klaus Kluck, Christian Altbürger, Constantin Schwab, Michael Allgäuer, Aysel Ahadova, Matthias Kloor, Peter Schirmacher, Solange Peters, Alwin Krämer, Petros Christopoulos, Albrecht Stenzinger
Tumour mutational burden: clinical utility, challenges and emerging improvements. Nature reviews. Clinical oncology (2024)
Paul Jank, Thomas Karn, Marion T van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, Knut Engels, Christine Solbach, Kurt Diebold, Frederic Marmé, Volkmar Mueller, Andreas Schneeweiß, Hans-Peter Sinn, Tanja Fehm, Christian Schem, Elmar Stickeler, Peter Andreas Fasching, Jan Budczies, Bärbel Felder, Valentina Nekljudova, Johannes Holtschmidt, Michael Untch, Carsten Denkert, Sibylle Loibl
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Rajiv Shah, Farastuk Bozorgmehr, Rajkumar Savai, Thorsten Stiewe, Solange Peters, Peter Schirmacher, Michael Thomas, Daniel N Kazdal, Petros Christopoulos, Albrecht Stenzinger
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma. British journal of cancer (2024)
Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin Assmann, Johannes Schnorbach, Anna-Lena Volckmar, Timothy Kwang Yong Tay, Hannah Goldschmid, Daniel Sw Tan, Michael Thomas, Daniel N Kazdal, Jan Budczies, Albrecht Stenzinger, Petros Christopoulos
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors. The journal of pathology. Clinical research 10 (2) (2024)
Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Rajiv Shah, Farastuk Bozorgmehr, Rajkumar Savai, Thorsten Stiewe, Solange Peters, Peter Schirmacher, Michael Thomas, Daniel N Kazdal, Petros Christopoulos, Albrecht Stenzinger
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma. British journal of cancer 131 (3) (2024)
Fabian Stögbauer, Susanne Beck, Iordanis Ourailidis, Jochen Hess, Christopher Poremba, Maren Lauterbach, Barbara Wollenberg, Anna Maria Stefanie Buchberger, Moritz Jesinghaus, Peter Schirmacher, Albrecht Stenzinger, Wilko Weichert, Melanie Boxberg, Jan Budczies
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer. British journal of cancer (2024)
Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Rajiv Shah, Farastuk Bozorgmehr, Rajkumar Savai, Thorsten Stiewe, Solange Peters, Peter Schirmacher, Michael Thomas, Daniel N Kazdal, Petros Christopoulos, Albrecht Stenzinger
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma. British journal of cancer 131 (3) (2024)
Paul Jank, Thomas Karn, Marion T van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, Knut Engels, Christine Solbach, Kurt Diebold, Frederic Marmé, Volkmar Mueller, Andreas Schneeweiß, Hans-Peter Sinn, Tanja Fehm, Christian Schem, Elmar Stickeler, Peter Andreas Fasching, Jan Budczies, Bärbel Felder, Valentina Nekljudova, Johannes Holtschmidt, Michael Untch, Carsten Denkert, Sibylle Loibl
An analysis of PIK3CA hotspot mutations and response to neoadjuvant therapy in breast cancer patients from four prospective clinical trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin Assmann, Johannes Schnorbach, Anna-Lena Volckmar, Timothy Kwang Yong Tay, Hannah Goldschmid, Daniel Sw Tan, Michael Thomas, Daniel N Kazdal, Jan Budczies, Albrecht Stenzinger, Petros Christopoulos
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors. The journal of pathology. Clinical research 10 (2) (2024)
Fabian Stögbauer, Susanne Beck, Iordanis Ourailidis, Jochen Hess, Christopher Poremba, Maren Lauterbach, Barbara Wollenberg, Anna Maria Stefanie Buchberger, Moritz Jesinghaus, Peter Schirmacher, Albrecht Stenzinger, Wilko Weichert, Melanie Boxberg, Jan Budczies
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer. British journal of cancer (2023)
Eva Romanovsky, Klaus Kluck, Iordanis Ourailidis, Michael Menzel, Susanne Beck, Markus Ball, Daniel Kazdal, Petros Christopoulos, Peter Schirmacher, Thorsten Stiewe, Albrecht Stenzinger, Jan Budczies
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis. Cell death discovery 9 (1) (2023)
Peter Andreas Fasching, Christopher W Szeto, Carsten Denkert, Stephen Charles Benz, Karsten E Weber, Patricia Spilman, Jan Budczies, Andreas Schneeweiß, Elmar Stickeler, Sabine Schmatloch, Christian Jackisch, Thomas Karn, Hans-Peter Sinn, Mathias Warm, Marion T van Mackelenbergh, Shahrooz Rabizadeh, Christian Schem, Ernst Heinmöller, Volkmar Mueller, Frederic Marmé, Patrick Soon-Shiong, Valentina Nekljudova, Michael Untch, Sibylle Loibl
Inferred immune-cell activity is an independent predictor of HER2 negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
A L Illert, Albrecht Stenzinger, Michael Bitzer, Peter Horak, V I Gaidzik, Y Möller, J Beha, Ö Öner, F Schmitt, S Laßmann, S Ossowski, C P Schaaf, M Hallek, Tim Henrik Brümmendorf, P Albers, T Fehm, P Brossart, H Glimm, Dirk Schadendorf, A Bleckmann, Christian H Brandts, I Esposito, E Mack, C Peters, C Bokemeyer, Stefan Fröhling, T Kindler, Hana Algül, V Heinemann, Hartmut Döhner, Ralf Christian Bargou, V Ellenrieder, P Hillemanns, F Lordick, A Hochhaus, M W Beckmann, T Pukrop, M Trepel, L Sundmacher, S Wesselmann, G Nettekoven, F Kohlhuber, O Heinze, Jan Budczies, M Werner, K Nikolaou, A J Beer, G Tabatabai, W Weichert, U Keilholz, M Boerries, Oliver Kohlbacher, J Duyster, Robert Thimme, T Seufferlein, P Schirmacher, N P Malek
The German Network for Personalized Medicine to enhance patient care and translational research. Nature medicine (2023)
Michael Menzel, Stephan Ossowski, Sebastian Kral, Patrick Metzger, Peter Horak, Ralf Marienfeld, Melanie Börries, Steffen Wolter, Markus Ball, Olaf Neumann, Sorin Armeanu-Ebinger, Christopher Schroeder, Uta Matysiak, Hannah Goldschmid, Vincent Schipperges, Axel Fürstberger, Michael Allgäuer, Timo Eberhardt, Jakob Niewöhner, Andreas Blaumeiser, Carolin Ploeger, Tobias Bernd Haack, Timothy Kwang Yong Tay, Olga Kelemen, Thomas Pauli, Martina Kirchner, Klaus Kluck, Alexander Ott, Marcus Renner, Jakob Admard, Axel Gschwind, Silke Lassmann, Hans Kestler, Falko Fend, Anna Lena Illert, Martin Werner, Peter Möller, Thomas Theodor Werner Seufferlein, Nisar Malek, Peter Schirmacher, Stefan Fröhling, Daniel N Kazdal, Jan Budczies, Albrecht Stenzinger
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients. NPJ precision oncology 7 (1) (2023)
E Rempel, K Kluck, S Beck, Iordanis Ourailidis, Daniel N Kazdal, Olaf Neumann, A L Volckmar, M Kirchner, H Goldschmid, Nicole Pfarr, W Weichert, Daniel Hübschmann, S Fröhling, Christian Sutter, C P Schaaf, P Schirmacher, V Endris, Albrecht Stenzinger, Jan Budczies
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD). NPJ precision oncology 6 (1) (2022)
Olaf Neumann, Timothy C Burn, Michael Allgäuer, Markus Ball, Martina Kirchner, Thomas Albrecht, Anna-Lena Volckmar, Susanne Beck, Volker Endris, Hannah Goldschmid, Ulrich Lehmann, Huriye Seker-Cin, Sebastian Uhrig, Stephanie Roessler, Jan Budczies, Stefan Fröhling, Thomas Longerich, Alex H Wagner, Arndt Vogel, Peter Schirmacher, Albrecht Stenzinger, Daniel N Kazdal
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. British journal of cancer 127 (8) (2022)
Jan Budczies, Klaus Kluck, Susanne Beck, Iordanis Ourailidis, Michael Allgäuer, Michael Menzel, Daniel N Kazdal, Lukas Perkhofer, Alexander Kleger, Peter Schirmacher, Thomas Seufferlein, Albrecht Stenzinger
Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types. The journal of pathology. Clinical research 8 (4) (2022)
Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Kriegsmann, Claus-Peter Heußel, Felix J Herth, Hauke Winter, Michael Meister, Thomas Muley, Torsten Goldmann, Stefan Fröhling, Martin Wermke, Cornelius F Waller, Amanda Tufman, Martin Reck, Solange Peters, Peter Schirmacher, Michael Thomas, Petros Christopoulos, Albrecht Stenzinger
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma. Cancer immunology, immunotherapy : CII (2021)
Mohamed Badr, Korinna Jöhrens, Michael Allgäuer, Melanie Boxberg, Wilko Weichert, Ingeborg Tinhofer, Carsten Denkert, Peter Schirmacher, Albrecht Stenzinger, Jan Budczies
Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer. Cancer immunology, immunotherapy : CII 68 (9) (2019)